Relationship Details
Celgene
→
Regulated entity regulator
→
the agency
Connected Entities
Entity A
Celgene
Type: person
Mentions: 0
Entity B
the agency
Type: person
Mentions: 2
Also known as: The AG
Evidence
The agency issued a warning letter to Celgene in 2000 for improper marketing.
The agency issued a warning letter to Celgene in 2000 for improper marketing.
Source Documents (1)
HOUSE_OVERSIGHT_028419.jpg
Congressional Report/Oversight Document
• 3.3 MB
This document, from a House Oversight file, details the business practices of the pharmaceutical company Celgene concerning its drugs Thalomid and Revlimid between 2000 and 2017. It outlines allegations of improper 'off-label' marketing, significant price increases, and aggressive strategies to extend its patent monopoly and block competition from generic drug makers. The document includes quotes from a Celgene executive, a federal regulatory agency, and a generic drug industry representative.
the agency's Other Relationships
Oversight response
Jeffrey Epstein
Strength: 1/10
View
Relationship Metadata
Type
Regulated entity regulator
Relationship Strength
6/10
Medium strength relationship
Source Documents
1
Extracted
2025-11-19 04:57
Last Updated
2025-11-19 04:57
Entity Network Stats
Celgene
18 relationships
the agency
2 relationships
Mutual connections
0
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship